BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE

被引:192
作者
APRELIKOVA, O
XIONG, Y
LIU, ET
机构
[1] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599
[4] UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599
关键词
D O I
10.1074/jbc.270.31.18195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of cyclin-dependent kinases (CDKs) by the CDK-activating kinase is required for the activation of CDK enzymes, Members of two families of CDK inhibitors, p16/p18 and p21/p27, become physically associated with and inhibit the activity of CDKs in response to a variety of growth-modulating signals, Here, we show that the representative members of both families of CDK inhibitors, p21(waf1,cip1), p27(kip1), and p18, can prevent the phosphorylation of their CDK partners, CDK2 and CDK6, by CDK-activating kinase. No direct interaction between CDK-activating kinase and the CDK inhibitors could be detected, suggesting that binding of these CDK inhibitors to CDK subunits renders CDK inaccessible to the CDK-activating kinase phosphorylation. These findings suggest that a general mechanism of CDK inhibitor function is to block the phosphorylation of CDK enzymes by CDK-activating kinase.
引用
收藏
页码:18195 / 18197
页数:3
相关论文
共 30 条
[1]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32
[2]   ACTIVATION OF HUMAN CYCLIN-DEPENDENT KINASES INVITRO [J].
DESAI, D ;
GU, Y ;
MORGAN, DO .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (05) :571-582
[3]   P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST [J].
DULIC, V ;
KAUFMANN, WK ;
WILSON, SJ ;
TLSTY, TD ;
LEES, E ;
HARPER, JW ;
ELLEDGE, SJ ;
REED, SI .
CELL, 1994, 76 (06) :1013-1023
[4]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[5]   THE MO15 GENE ENCODES THE CATALYTIC SUBUNIT OF A PROTEIN-KINASE THAT ACTIVATES CDC2 AND OTHER CYCLIN-DEPENDENT KINASES (CDKS) THROUGH PHOSPHORYLATION OF THR161 AND ITS HOMOLOGS [J].
FESQUET, D ;
LABBE, JC ;
DERANCOURT, J ;
CAPONY, JP ;
GALAS, S ;
GIRARD, F ;
LORCA, T ;
SHUTTLEWORTH, J ;
DOREE, M ;
CAVADORE, JC .
EMBO JOURNAL, 1993, 12 (08) :3111-3121
[6]   A NOVEL CYCLIN ASSOCIATES WITH MO15/CDK7 TO FORM THE CDK-ACTIVATING KINASE [J].
FISHER, RP ;
MORGAN, DO .
CELL, 1994, 78 (04) :713-724
[7]   INHIBITION OF CDK2 ACTIVITY IN-VIVO BY AN ASSOCIATED 20K REGULATORY SUBUNIT [J].
GU, Y ;
TURCK, CW ;
MORGAN, DO .
NATURE, 1993, 366 (6456) :707-710
[8]   GROWTH SUPPRESSION BY P18, A P16(INK4/MTS1)-RELATED AND P14(INK4B/MTS2)-RELATED CDK6 INHIBITOR, CORRELATES WITH WILD-TYPE PRB FUNCTION [J].
GUAN, KL ;
JENKINS, CW ;
LI, Y ;
NICHOLS, MA ;
WU, XY ;
OKEEFE, CL ;
MATERA, AG ;
XIONG, Y .
GENES & DEVELOPMENT, 1994, 8 (24) :2939-2952
[9]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[10]  
HARPER JW, 1993, CELL, V75, P805